Current concepts of pheochromocytoma

Golden, 2009, Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review, The Journal of Cinical Endocrinology and Metabolism, 94, 1853, 10.1210/jc.2008-2291 Van der Horst-Schrivers, 2006, Preoperative pharmacological management of phaeochromocytoma, The Netherlands Journal of Medicine, 64, 290 Shen, 2010, One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy, Archives of Surgery, 145, 893, 10.1001/archsurg.2010.159 Gagner, 1996, Is laparoscopic adrenalectomy indicated for pheochromocytomas?, Surgery, 120, 1076, 10.1016/S0039-6060(96)80058-4 Ulchaker, 1999, Successful outcomes in pheochromocytoma surgery in the modern era, The Journal of Urology, 161, 764, 10.1016/S0022-5347(01)61762-2 Bornstein, 2006, Genetic testing in pheochromocytoma: increasing importance for clinical decision making, Annals of the New York Academy of Sciences, 1073, 94, 10.1196/annals.1353.010 Pasquali, 2008, Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells, Journal of Molecular Endocrinology, 40, 263, 10.1677/JME-08-0012 Bauters, 2003, Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes, Journal of Medical Genetics, 40, e75, 10.1136/jmg.40.6.e75 Conzo, 2012, Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene, Clinical Endocrinology, 77, 934, 10.1111/j.1365-2265.2012.04412.x Murphy, 2010, Trends in adrenalectomy: a recent national review, Surgical Endoscopy, 24, 2518, 10.1007/s00464-010-0996-z Van Heerden, 1982, Pheochromocytoma: current status and changing trends, Surgery, 91, 367 Marsh, 1999, Anesthesia for adrenal surgery, 131 Conzo, 2012, Laparoscopic treatment of pheochromocytomas smaller or larger than 6 cm A clinical retrospective study on 44 patients. Laparoscopic adrenalectomy for pheochromocytoma, Annali italiani di chirurgia Pacak, 2001, Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma, Annals of Internal Medicine, 134, 315, 10.7326/0003-4819-134-4-200102200-00016 Timmers, 2012, Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, Journal of the National Cancer Institute, 104, 700, 10.1093/jnci/djs188 Mulligan, 1994, Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC, Nature Genetics, 6, 70, 10.1038/ng0194-70 Attie_-Bitach, 1998, Expression of the RET proto-oncogene in human embryos, American Journal of Medical Genetics, 80, 481, 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO;2-6 Plaza-Menacho, 2011, Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism, The Journal of Biological Chemistry, 286, 17292, 10.1074/jbc.M110.168500 Neumann, 2002, Germ- line mutations in nonsyndromic pheochromocytoma, The New England Journal of Medicine, 346, 1459, 10.1056/NEJMoa020152 American Thyroid Association Guidelines Task Force, 2009, Medullary thyroid cancer: management guidelines of the American Thyroid Association, Thyroid: Official Journal of the American Thyroid Association, 19, 565, 10.1089/thy.2008.0403 Eisenhofer, 2001, Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes, The Journal of Cinical Endocrinology and Metabolism, 86, 1999, 10.1210/jcem.86.5.7496 Stolle, 1998, Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene, Human Mutation, 12, 417, 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K Gutmann, 1997, The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2, Jama: the Journal of the American Medical Association, 278, 51, 10.1001/jama.1997.03550010065042 Viskochil, 1990, Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus, Cell, 62, 187, 10.1016/0092-8674(90)90252-A Bausch, 2007, Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1, The Journal of Cinical Endocrinology and Metabolism, 92, 2784, 10.1210/jc.2006-2833 Mannelli, 2009, Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas, The Journal of Cinical Endocrinology and Metabolism, 94, 1541, 10.1210/jc.2008-2419 Gimenez-Roqueplo, 2003, Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas, Cancer Research, 63, 5615 Baysal, 2000, Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, Science, 287, 848, 10.1126/science.287.5454.848 Ricketts, 2010, Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD, Human Mutation, 31, 41, 10.1002/humu.21136 Dahia, 2005, Novel pheochromocytoma susceptibility loci identified by integrative genomics, Cancer Research, 65, 9651, 10.1158/0008-5472.CAN-05-1427 Qin, 2010, Germline mutations in TMEM127 confer susceptibility to pheochromocytoma, Nature Genetics, 42, 229, 10.1038/ng.533 Yao, 2010, Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas, Jama: the Journal of the American Medical Association, 304, 2611, 10.1001/jama.2010.1830 Burnichon, 2011, A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma, European Journal of Endocrinology, 164, 141, 10.1530/EJE-10-0758 Comino-Me・dez, 2011, Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma, Nature Genetics, 43, 663, 10.1038/ng.861 Grandori, 2000, The Myc/Max/Mad network and the transcriptional control of cell behavior, Annual Review of Cell and Developmental Biology, 16, 653, 10.1146/annurev.cellbio.16.1.653 Hopewell, 1995, The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max, Molecular and Cellular Biology, 15, 3470, 10.1128/MCB.15.7.3470 Emerson, 2003, Use of a ‘hospital-at-home’ service for patient optimization before resection of phaeochromocytoma, British Journal of Anaesthesia, 90, 380, 10.1093/oxfordjournals.bja.a000403 Toniato, 2007, Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?, Surgery, 141, 723, 10.1016/j.surg.2006.10.012 Pullerits, 1988, Anaesthesia for phaeochromocytoma, Canadian Journal of Anaesthesia, 35, 526, 10.1007/BF03026905 Levine, 1984, The evaluation and management of pheochromocytomas, Advances in Surgery, 17, 281 Tauzin-Fin, 2004, Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, British Journal of Anaesthesia, 92, 512, 10.1093/bja/aeh083 Prys-Roberts, 2002, Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma, World Journal of Surgery, 26, 1037, 10.1007/s00268-002-6667-z Perry, 1972, The anesthetic management of pheochromocytoma effect of preoperative adrenergic blocking drugs, Anesthesia and Analgesia, 51, 36, 10.1213/00000539-197201000-00010 Deoreo, 1974, Preoperative blood transfusion in the safe surgical management of pheochromocytoma: a review of 46 cases, The Journal of Urology, 111, 715, 10.1016/S0022-5347(17)60053-3 Boutros, 1990, Perioperative management of 63 patients with pheochromocytoma, Cleveland Clinic Journal of Medicine, 57, 613, 10.3949/ccjm.57.7.613 Newell, 1988, Plasma catecholamine changes during excision of pheochromocytoma, Surgery, 104, 1064 Steinsapir, 1997, Metyrosine and pheochromocytoma, Archives of Internal Medicine, 157, 901, 10.1001/archinte.1997.00440290087009 Zhu, 2010, Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma, Endocrine, 38, 254, 10.1007/s12020-010-9381-x Weingarten, 2010, Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma, Urology, 76, 508.e6, 10.1016/j.urology.2010.03.032 Lebuffe, 2005, The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas, Anaesthesia, 60, 439, 10.1111/j.1365-2044.2005.04156.x Conzo, 2013, Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series, International Journal of Surgery. [international Journal of Surgery (London, England)], 11, 152, 10.1016/j.ijsu.2012.12.007 Conzo, 2013, Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma. A retrospective study of 48 cases, The American Surgeon, 84, 417 Cotesta, 2009, Clinical experience with pheochromocytoma in a single centre over 16 years, High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension, 16, 183, 10.2165/11530430-000000000-00000 Remine, 1974, Current management of pheochromocytoma, Annals of Surgery, 179, 740, 10.1097/00000658-197405000-00029 Lombardi, 2005, Pheochromocytoma: role of preoperative diagnosis in the assessment of malignancy risk and in the choice of surgical approach, I Supplementi di Tumori: Official Journal of Societa Italiana di Cancerologia … [et al.], 4, S211 Cheah, 2002, Laparoscopic adrenalectomy for pheochromocytoma, World Journal of Surgery, 26, 1048, 10.1007/s00268-002-6669-x Li, 2001, Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy, Surgery, 130, 1072, 10.1067/msy.2001.118373 Conzo, 2009, Adrenal incidentalomas in the laparoscopic era and the role of correct surgical indications: observations from 255 consecutive adrenalectomies in an Italian series, Canadian Journal of Surgery. Journal Canadien de Chirurgie, 52, E281 Amar, 2005, Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma, The Journal of Cinical Endocrinology and Metabolism, 90, 2110, 10.1210/jc.2004-1398 Stenstroom, 1988, Long-term results in 64 patients operated upon for pheochromocytoma, Acta Medica Scandinavica, 223, 345, 10.1111/j.0954-6820.1988.tb15883.x H. John, W.H. Ziegler, D. Hauri, et al, Pheochromocytomas: can malignant potential be predicted?, Urology. Yoshida, 2001, Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma, Archives of Orthopaedic and Trauma Surgery, 121, 598, 10.1007/s004020100305 Lenders, 2005, Phaeochromocytoma, Lancet, 366, 665, 10.1016/S0140-6736(05)67139-5